Corvus Pharmaceuticals, Inc. (CRVS)

16.54 -0.03 (-0.18%) USD  |  NASDAQ  |  Feb 23, 12:18
More

Corvus Pharmaceuticals Properties (Per Share)

Properties (Per Share) Chart

View Properties (Per Share) for CRVS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Properties (Per Share) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Properties (Per Share) Range, Past 5 Years

View Properties (Per Share) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Properties (Per Share) Benchmarks

View Properties (Per Share) Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. --
Plus Therapeutics, Inc. --
Geron Corp. --
Jaguar Health, Inc. Upgrade
Krystal Biotech, Inc. Upgrade